Saejosetchh

 GuillainBarré syndrome, or GBS, was recently described as a rare side effect following receipt of adenovirusbased COVID19 vaccines, such as the J&J/Janssen version used in the US GBS has also been found to be a rare consequence of influenza vaccinationDescription Guillain Barre Syndrome is a rare neurologic condition that leads to weakness and sensory impairments Patients with Guillain Barre often have high rehabilitation needs and benefit greatly from intensive rehabilitation from an interdisciplinary rehabilitation This talk will cover an overview of the disease, initial medical management, treatment, therapy strategies, and A case of GuillainBarre has also been identified in a patient who got the Pfizer vaccine In India, there are reports of seven severe cases of GuillainBarré syndrome 10 to 14 days after the first dose of AstraZeneca's vaccine Six were women, all had facial paralysis, "all progressed to quadriplegia, and six required respiratory support Andrew S Stor...